News | March 06, 2026
Lonza to set up Global Capability Centre in Hyderabad
Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process
Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process
Pivya is Alembic’s first branded pharmaceutica product in the US and is being marketed through Alembic Therapeutics LLC
Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
Built on the Percept Platform and enhanced with BrainSense technology, the system can adjust stimulation levels in real time, responding to brain signals without manual intervention
A next-generation, cell-based immunotherapy, CAR-T therapy engineers a patient’s own immune cells to detect and destroy cancer
SYNT-101 is a once-daily oral pill engineered to redirect nutrient absorption beyond the small intestine’s duodenum
This study evaluated a difficult-to-treat Crohn's disease patient population
The company has shown remarkable growth, posting a three-year CAGR of around 75% with an ARR of roughly Rs 100 crore and impressive gross margins
Achondroplasia, a rare genetic disorder, causes skeletal dysplasia and often increases the risk of muscular, neurological, and cardiorespiratory complications
The LIFT-PD study will enroll 75 Parkinson’s patients experiencing apathy across 16 sites in Germany, Bulgaria, Poland and Spain
Subscribe To Our Newsletter & Stay Updated
